Pfizer plans on sweetening offer for obesity drugmaker Metsera, source says

Pfizer plans to sweeten its bid for Metsera , a person familiar with the matter told Reuters, after a judge denied its ...
News Nation on MSN

Eli Lilly, Novo Nordisk near deal on weight loss drug costs: Report

According to Reuters, Lilly could offer the lowest dose of its popular weight loss drug Zepbound at $149 a month, and Novo’s ...
Stocktwits on MSN

Can Novo Nordisk’s ‘Attractive’ Fundamentals Outweigh Slowing Wegovy Sales And A $149 Price Cap?

Novo Nordisk cut its 2025 profit and sales forecasts as slower GLP-1 growth and pricing pressure hit margins. ・Q3 sales rose ...

Trump Negotiating Deal With Ozempic Maker to Sell Some Weight-Loss Drugs for $149

Novo Nordisk, as well as Eli Lilly, would gain Medicare and Medicaid coverage for their blockbuster weight-loss drugs.
IPWatchdog

Novo Nordisk Challenges to CMS Single Source Drug Determinations Fall to IRA’s Bar Against Judicial Review

“[T]he Third Circuit found that CMS’ treatment of six [Novo Nordisk] products as a single drug was ultimately precluded by the IRA’s bar against judicial review.” Yesterday, the U.S. Court of ...